These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18046432)

  • 21. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y; Damle A
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
    Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients.
    Verdecchia P; Sleight P; Avanzini F; de Simone G; Pede S; Perticone F; Schillaci G; Vanuzzo D; Angeli F; Reboldi GP; Maggioni AP
    Ital Heart J; 2003 Jul; 4(7):479-83. PubMed ID: 14558300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study.
    Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y
    Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study.
    Niiranen TJ; Jula AM; Kantola IM; Karanko H; Reunanen A
    J Hum Hypertens; 2007 Oct; 21(10):788-94. PubMed ID: 17637793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.
    Verdecchia P; Angeli F; Gattobigio R; Sardone M; Pede S; Reboldi GP
    Am J Hypertens; 2006 May; 19(5):493-9. PubMed ID: 16647622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki eye study.
    Topouzis F; Coleman AL; Harris A; Jonescu-Cuypers C; Yu F; Mavroudis L; Anastasopoulos E; Pappas T; Koskosas A; Wilson MR
    Am J Ophthalmol; 2006 Jul; 142(1):60-67. PubMed ID: 16815251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in ST segment on ECG of hypertensive patients].
    Riabykina GV; Liutikova LN; Saidova MA; Botvina IuV; Kozhemiakina ESh; Shchedrina EV; Sobolev AV
    Ter Arkh; 2008; 80(5):67-73. PubMed ID: 18590119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials.
    Zhang K; Chen J; Liu Y; Wang T; Wang L; Wang J; Huang H
    J Hum Hypertens; 2013 Nov; 27(11):698-706. PubMed ID: 23535988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM.
    Puig JG; Calvo C; Luurila O; Luurila H; Sulosaari S; Strandberg A; Ghezzi C
    J Hum Hypertens; 2007 Dec; 21(12):917-24. PubMed ID: 17581601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    Blood Press; 2014 Apr; 23(2):71-80. PubMed ID: 23721506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining normal ambulatory blood pressure in relation to target organ damage and prognosis.
    Verdecchia P; Porcellati C
    Am J Hypertens; 1993 Jun; 6(6 Pt 2):207S-210S. PubMed ID: 8347320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent knowledge on the role of diastolic blood pressure in hypertensive patients on treatment].
    Leonetti G; Cuspidi C
    Recenti Prog Med; 2008 Apr; 99(4):191-9. PubMed ID: 18595632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.